172 related articles for article (PubMed ID: 10740283)
1. New role for epoxyeicosatrienoic acids as anti-inflammatory mediators.
Campbell WB
Trends Pharmacol Sci; 2000 Apr; 21(4):125-7. PubMed ID: 10740283
[No Abstract] [Full Text] [Related]
2. Is EDHF an epoxyeicosatrienoic acid?
Quilley J; McGiff JC
Trends Pharmacol Sci; 2000 Apr; 21(4):121-4. PubMed ID: 10740282
[No Abstract] [Full Text] [Related]
3. Epoxyeicosatrienoic acids and endothelium-dependent responses.
Campbell WB; Fleming I
Pflugers Arch; 2010 May; 459(6):881-95. PubMed ID: 20224870
[TBL] [Abstract][Full Text] [Related]
4. The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling.
Fleming I
Vascul Pharmacol; 2016 Nov; 86():31-40. PubMed ID: 26975734
[TBL] [Abstract][Full Text] [Related]
5. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids.
Spiecker M; Liao JK
Arch Biochem Biophys; 2005 Jan; 433(2):413-20. PubMed ID: 15581597
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome p450 and vascular homeostasis.
Fleming I
Circ Res; 2001 Oct; 89(9):753-62. PubMed ID: 11679404
[TBL] [Abstract][Full Text] [Related]
7. Brain synthesis and cerebrovascular action of cytochrome P-450/monooxygenase metabolites of arachidonic acid.
Ellis EF; Amruthesh SC; Police RJ; Yancey LM
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():201-4. PubMed ID: 1825540
[No Abstract] [Full Text] [Related]
8. To b'EET or not to b'EET? That is the question!
Ahluwalia A
Clin Sci (Lond); 2003 Oct; 105(4):399-401. PubMed ID: 12892558
[TBL] [Abstract][Full Text] [Related]
9. The nitric oxide- and prostaglandin-independent component of the renal vasodilator effect of thimerosal is mediated by epoxyeicosatrienoic acids.
Chen YJ; Jiang H; Quilley J
J Pharmacol Exp Ther; 2003 Mar; 304(3):1292-8. PubMed ID: 12604709
[TBL] [Abstract][Full Text] [Related]
10. Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels.
Archer SL; Gragasin FS; Wu X; Wang S; McMurtry S; Kim DH; Platonov M; Koshal A; Hashimoto K; Campbell WB; Falck JR; Michelakis ED
Circulation; 2003 Feb; 107(5):769-76. PubMed ID: 12578883
[TBL] [Abstract][Full Text] [Related]
11. 5,6-epoxyeicosatrienoic acid mediates the enhanced renal vasodilation to arachidonic acid in the SHR.
Pomposiello SI; Quilley J; Carroll MA; Falck JR; McGiff JC
Hypertension; 2003 Oct; 42(4):548-54. PubMed ID: 12939232
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.
Node K; Huo Y; Ruan X; Yang B; Spiecker M; Ley K; Zeldin DC; Liao JK
Science; 1999 Aug; 285(5431):1276-9. PubMed ID: 10455056
[TBL] [Abstract][Full Text] [Related]
13. Whatever happened to the epoxyeicosatrienoic Acid-like endothelium-derived hyperpolarizing factor? The identification of novel classes of lipid mediators and their role in vascular homeostasis.
Frömel T; Fleming I
Antioxid Redox Signal; 2015 May; 22(14):1273-92. PubMed ID: 25330284
[TBL] [Abstract][Full Text] [Related]
14. Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole.
Arima S; Endo Y; Yaoita H; Omata K; Ogawa S; Tsunoda K; Abe M; Takeuchi K; Abe K; Ito S
J Clin Invest; 1997 Dec; 100(11):2816-23. PubMed ID: 9389747
[TBL] [Abstract][Full Text] [Related]
15. Origin and function of epoxyeicosatrienoic acids in vascular endothelial cells: more than just endothelium-derived hyperpolarizing factor?
Hoebel BG; Steyrer E; Graier WF
Clin Exp Pharmacol Physiol; 1998 Oct; 25(10):826-30. PubMed ID: 9784924
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 metabolites of arachidonic acid: rapid incorporation and hydration of 14,15-epoxyeicosatrienoic acid in arterial smooth muscle cells.
Fang X; Kaduce TL; Weintraub NL; Spector AA
Prostaglandins Leukot Essent Fatty Acids; 1997 Oct; 57(4-5):367-71. PubMed ID: 9430380
[TBL] [Abstract][Full Text] [Related]
17. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals.
Hecker M; Bara AT; Bauersachs J; Busse R
J Physiol; 1994 Dec; 481 ( Pt 2)(Pt 2):407-14. PubMed ID: 7738833
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 2C is an EDHF synthase in coronary arteries.
Fisslthaler B; Popp R; Kiss L; Potente M; Harder DR; Fleming I; Busse R
Nature; 1999 Sep; 401(6752):493-7. PubMed ID: 10519554
[TBL] [Abstract][Full Text] [Related]
19. Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries.
Fisslthaler B; Hinsch N; Chataigneau T; Popp R; Kiss L; Busse R; Fleming I
Hypertension; 2000 Aug; 36(2):270-5. PubMed ID: 10948089
[TBL] [Abstract][Full Text] [Related]
20. Having a heart attack? Avoid the "HETE"!
Granville DJ; Gottlieb RA
Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H485-7. PubMed ID: 16603694
[No Abstract] [Full Text] [Related]
[Next] [New Search]
